Merkelbach-Bruse S - Search Results

1

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.

Wagener-Ryczek S, Heydt C, Süptitz J, Michels S, Falk M, Alidousty C, Fassunke J, Ihle MA, Tiemann M, Heukamp L, Wolf J, Büttner R, Merkelbach-Bruse S. Wagener-Ryczek S, et al. BMC Cancer. 2020 May 12;20(1):408. doi: 10.1186/s12885-020-06920-3. BMC Cancer. 2020. PMID: 32397977 Free PMC article.

2

Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.

Wardelmann E, Losen I, Hans V, Neidt I, Speidel N, Bierhoff E, Heinicke T, Pietsch T, Büttner R, Merkelbach-Bruse S. Wardelmann E, et al. Int J Cancer. 2003 Oct 10;106(6):887-95. doi: 10.1002/ijc.11323. Int J Cancer. 2003. PMID: 12918066

3

c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study.

Pauls K, Wardelmann E, Merkelbach-Bruse S, Büttner R, Zhou H. Pauls K, et al. Virchows Arch. 2004 Dec;445(6):651-4. doi: 10.1007/s00428-004-1112-3. Epub 2004 Sep 29. Virchows Arch. 2004. PMID: 15455230

4

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations.

Wardelmann E, Thomas N, Merkelbach-Bruse S, Pauls K, Speidel N, Büttner R, Bihl H, Leutner CC, Heinicke T, Hohenberger P. Wardelmann E, et al. Lancet Oncol. 2005 Apr;6(4):249-51. doi: 10.1016/S1470-2045(05)70097-8. Lancet Oncol. 2005. PMID: 15811621 No abstract available.

5

Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women.

Haas S, Park TW, Voigt E, Büttner R, Merkelbach-Bruse S. Haas S, et al. Int J Mol Med. 2005 Nov;16(5):815-9. Int J Mol Med. 2005. PMID: 16211249

6

Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy.

Wardelmann E, Büttner R, Merkelbach-Bruse S, Schildhaus HU. Wardelmann E, et al. Virchows Arch. 2007 Oct;451(4):743-9. doi: 10.1007/s00428-007-0473-9. Epub 2007 Aug 14. Virchows Arch. 2007. PMID: 17701051 Review.

7

[Therapeutic targets in gastrointestinal stromal tumors].

Wardelmann E, Schildhaus HU, Merkelbach-Bruse S, Büttner R. Wardelmann E, et al. Verh Dtsch Ges Pathol. 2006;90:73-9. Verh Dtsch Ges Pathol. 2006. PMID: 17867582 German.

8

[Molecular targets for diagnostics and therapy--new challenges for pathologists].

Merkelbach-Bruse S, Wardelmann E, Heukamp L, Friedrichs N, Büttner R. Merkelbach-Bruse S, et al. Verh Dtsch Ges Pathol. 2005;89:111-5. Verh Dtsch Ges Pathol. 2005. PMID: 18035680 German.

9

[Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].

Wardelmann E, Merkelbach-Bruse S, Büttner R, Schildhaus HU. Wardelmann E, et al. Verh Dtsch Ges Pathol. 2007;91:165-8. Verh Dtsch Ges Pathol. 2007. PMID: 18314611 German.

10

Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene.

Schildhaus HU, Cavlar T, Binot E, Büttner R, Wardelmann E, Merkelbach-Bruse S. Schildhaus HU, et al. J Pathol. 2008 Oct;216(2):176-82. doi: 10.1002/path.2393. J Pathol. 2008. PMID: 18686281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters